Clinical Trials for Melinta Therapeutics

Explore 5 clinical trials worldwide

Showing 1-5 of 5 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Melinta Therapeutics

Clinical Trials (5)

NCT06774144
Rezafungin Prophylaxis in Liver Transplant
PHASE3Enrolling by invitation
385 participants
Started: Oct 15, 2025 · Completed: Dec 31, 2028
2 conditions2 sponsors1 location
NCT06672978
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Meropenem-Vaborbactam in Children With Complicated Urinary Tract Infection, Including Acute Pyelonephritis
PHASE2Recruiting
66 participants
Started: Jun 3, 2025 · Completed: Jul 31, 2027
2 conditions2 sponsors22 locations
NCT05599295
Study to Evaluate the Safety of Intravenous Oritavancin for the Treatment of Children With Skin Infections
PHASE2Recruiting
75 participants
Started: Jun 15, 2023 · Completed: Jan 15, 2026
1 condition1 sponsor29 locations
NCT02687906
Dose-finding, Pharmacokinetics, and Safety of VABOMERE in Pediatric Subjects With Bacterial Infections
PHASE1Active, not recruiting
39 participants
Started: Jul 31, 2016 · Completed: Dec 31, 2025
1 condition2 sponsors9 locations
NCT02134301
Open-Label, Dose-Finding, Pharmacokinetics, Safety and Tolerability Study of Oritavancin in Pediatric Patients With Suspected or Confirmed Bacterial Infections
PHASE1Active, not recruiting
41 participants
Started: May 31, 2014 · Completed: Dec 31, 2025
1 condition1 sponsor8 locations